Download Curriculum Vitae - University of Utah

Curriculum Vitae
Jeffery T. Zobell, Pharm.D.
73 East 550 South
Kaysville, UT 84037
(801) 547-0505
[email protected]
Education
2002-2006
The University of Arizona, Tucson, Arizona
Doctor of Pharmacy
Employment
2009-present
Team Leader-Children’s Medical/Surgical Unit; Infant
Medical/Surgical Unit, Intermountain Primary Children’s Hospital,
Intermountain Healthcare, Salt Lake City, Utah
Start Date: July 2009. Responsibilities: Clinical floor pharmacist,
attending inter-disciplinary rounds, patient-family medication
education, pharmacokinetics, precepting residents and students,
project preceptor for resident projects
2009-present
Clinical Pharmacist, Intermountain Cystic Fibrosis Pediatric
Center, Salt Lake City, Utah
Start Date: July 2009. Responsibilities: Preceptor for Cystic
Fibrosis ambulatory care pharmacy practice residency, patientfamily medication education, quality improvement and clinical
research projects
2008-2009
Neonatal Intensive Care Unit Pharmacist, Intermountain Primary
Children’s Medical Center, Intermountain Healthcare, Salt Lake
City, Utah
2007-2008
General Clinical Pharmacist, Intermountain Primary Children’s
Medical Center, Intermountain Healthcare, Salt Lake City, Utah
2006-2007
Pharmacy Practice Resident, Intermountain Primary Children’s
Medical Center, Intermountain Healthcare, Salt Lake City, Utah
2002-2006
Pharmacy Intern, Banner Desert Pharmacy, Banner Desert Medical
Center, Banner Health System, Mesa, Arizona
2000-2002
Pharmacy Technician, Banner Desert Pharmacy, Banner Desert
Medical Center, Banner Health System, Mesa, Arizona
5/8/2017
Publications
Louie JM, Young DC, Zobell JT, Bhakta ZN, et al. Safety of continuous infusion betalactam antibiotics in adult cystic fibrosis patients during an acute pulmonary
exacerbation. Pediatr Pulmonol. 2014; Suppl 38:329.
Zobell JT, Ferdinand C, Kemper A, Gorney N, et al. Efficacy of high dose vs. standard
dose of ceftazidime in pediatric CF patients. Pediatr Pulmonol. 2014; Suppl 38:305
Zobell JT, Epps K, Kittell F, Sema C, et al. Antibiotic utilization in CF exacerbations: a
pharmacist approach. Pediatr Pulmonol. 2014; Suppl 38:303
Holcomb KA, Young DC, Zobell JT, Bhakta ZN, et al. Survey of antibiotic utilization
for treatment of Mycobacterium abscessus infection amongst CF accredited care centers.
Pediatr Pulmonol. 2014; Suppl 38:285
Zobell JT, Epps K, Young DC, Montague M, Olson J, Ampofo K, Chin M, Marshall BC,
Dasenbrook E. Utilization of antibiotics for methicillin-resistant Staphylococcus aureus
infection in CF patients. Pediatr Pulmonol. Article in press.
Hunt T, Zobell JT, MacKay M, McDonald CM, et al. Sterility analysis of cystic fibrosis
liquid multivitamins. Pediatr Pulmonol. 2013; Suppl 36:299
Zobell JT, Darnell L, Ferdinand C, Kemper A, et al. High dose intermittent ceftazidime
administration in pediatric cystic fibrosis patients. Pediatr Pulmonol. 2013; Suppl
36:293.
Zobell JT, Epps K, Young DC, Hatch M, et al. Utilization of antibiotics for methicillinresistant Staphylococcus aureus infection in CF patients. Pediatr Pulmonol. 2013; Suppl
36:294.
Bhakta ZN, Young DC, Zobell JT, Kuhn RJ, et al. A survey of the pharmacist’s role at
US CFF-accredited centers—a director’s perspective. Pediatr Pulmonol. 2013; Suppl
36:518.
Chatfield BA, Zobell JT, Stewart J, Hamilton J. Improved delivery time from inpatient
admission to antibiotic administration for the CF patient. Pediatr Pulmonol. 2013; Suppl
36:650.
Young DC, Zobell JT, Kuhn RJ, Chin M, et al. A survey of pharmacists providing care
at US CFF-accredited centers. Pediatr Pulmonol. 2013; Suppl 36:653.
Sherwin CMT, Zobell JT, Stockmann C, McCrory BE, et al. Pharmacokinetic and
pharmacodynamic optimization of intravenous tobramycin dosing among children with
cystic fibrosis. J Pharmacokinet Pharmacodyn. 2014;41(1):71-9.
5/8/2017
Jeffery Zobell
3
Stockman C, Sherwin CMT, Zobell JT, Lubsch, L, et al. Population pharmacokinetics of
intermittent vancomycin in children with cystic fibrosis. Pharmacother. 2013;
33(12):1288-96.
Zobell JT, Kemper AL, Young DC. The use of doripenem in pediatric cystic fibrosis
patients in case of meropenem shortages. Pediatr Pulmonol. 2014;49(3):E48-51
Zobell JT, Young DC, Waters CD, Stockmann C, et al. Optimization of antipseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: VI. Executive
summary. Pediatr Pulmonol. 2013; 48:525-537.
Young DC, Zobell JT, Stockmann C, Waters CD, et al. Optimization of antipseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: V.
aminoglycosides. Pediatr Pulmonol. 2013; 48(11):1047-1061.
Zobell JT, Ferdinand C, Young DC. Continuous infusion meropenem and ticarcillinclavulanate in pediatric cystic fibrosis patients. Pediatr Pulmonol. 2014;49(3):302-6
Young DC, Zobell JT, Waters CD, Ampofo K, et al. Optimization of anti-pseudomonal
antibiotics for cystic fibrosis pulmonary exacerbations: IV. colistimethate sodium.
Pediatr Pulmonol. 2013; 48(1):1-7.
Stockmann C, Sherwin C, Zobell JT, Young DC, et al. Optimization of antipseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: III.
fluoroquinolones. Pediatr Pulmonol. 2013; 48(3):211-220.
Zobell JT, Waters CD, Young DC, Stockmann, C, et al. Optimization of antipseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins
and penicillins. Pediatr Pulmonol. 2013; 48(2):107-122.
Zobell JT, Young DC, Waters CD, Stockmann C, et al. Optimization of antipseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: I. aztreonam and
carbapenems. Pediatr Pulmonol. 2012; 47(12):1147-1158.
Zobell JT, Young DC, Chatfield BA. Intermittent and extended-infusion beta-lactam
utilization in cystic fibrosis. Pediatr Pulmonol. 2013; 48:622-623.
Pohl JF, Zobell J, Lin E, Korgenski K, et al. Clostridium difficile infection and proton
pump inhibitor use in hospitalized pediatric cystic fibrosis patients. Gastroenterol Res
Pract. 2011; 2011:345012.
Zobell JT, Stockmann C, Young DC, Cash J, et al. Population pharmacokinetic and
pharmacodynamic modeling of high dose intermittent ticarcillin-clavulanate
administration in pediatric cystic fibrosis patients. Clin Ther. 2011; 33:1844-1850.
5/8/2017
Jeffery Zobell
4
Leonard W, Zobell JT, Ensign R, Korgenski K, et al. Retrospective evaluation of
appropriate duration of intravenous antibiotic therapy for acute CF exacerbations.
Pediatr Pulmonol. 2011; Suppl 34:330
Zobell JT, Stockmann C, Young DC, Cash J, et al. Population pharmacokinetic (PK) and
pharmacodynamic (PD) modeling of ticarcillin-clavulanate in pediatric CF patients.
Pediatr Pulmonol. 2011; Suppl 34:277
Zobell JT, Young D, Waters CD, Ampofo K, et al. A survey of the utilization of antipseudomonal beta-lactam therapy in cystic fibrosis patients. Pediatr Pulmonol. 2011;
46:987-990.
Zobell JT, Ampofo K, Cash J, Korgenski K, Chatfield BA. High dose intermittent
ticarcillin-clavulanate administration in pediatric cystic fibrosis patients. J Cyst Fibros.
2010; 9:280-283.
Lin E, Zobell J, MacKay M, Korgenski K, et al. Role of acid suppression as a risk factor
in Clostridium difficle infections in pediatric CF patients. Pediatr Pulmonol. 2009;
Suppl 32:526.
Chatfield BA, Zobell J, Seidelman J, Mundorf M, et al. Compliance in prescribing of CF
medications of a CF specific medication tracker. Pediatr Pulmonol. 2009; Suppl 32:508
Halton K, Zobell J, MacKay M, Ensign R, et al. Evaluation of the effectiveness of a
MRSA eradication protocol in pediatric CF patients. Pediatr Pulmonol. 2009; Suppl
32:366.
Zobell J, Olson J, Cash J, Mitchell M, et al. Evaluation of a change in once daily
tobramycin pharmacokinetic monitoring in pediatric CF patients. Pediatr Pulmonol.
2009; Suppl 32:493.
Zobell JT, Hoopes L, Hyer J, MacKay M, et al. Prospective evaluation of the delivery of
intravenous antibiotics during CF exacerbations. Pediatr Pulmonol. 2008; Suppl 31:575
McDonald K, Zobell J, MacKay M. Vitamin D status in children with CF. Pediatr
Pulmonol. 2008; Suppl 31:656.
Zobell, JT, Hyer J, MacKay M, Koopmeiners K, et al. Improving delivery of intravenous
antibiotics during CF exacerbations. Pediatr Pulmonol. 2007; Suppl 30:370.
Chatfield BA, Seidelman J, Hyer JS, Zobell JT, et al. Medtracker: utilizing a patient
medication tracking system to improve quality of care in a pediatric cystic fibrosis clinic.
Pediatr Pulmonol. 2007; Suppl 30:370-1.
5/8/2017
Jeffery Zobell
5
Presentations
Oct 2014
Difficult to Treat Infections: Methicillin-resistant S. aureus
(MRSA). Short course session. North American Cystic Fibrosis
Conference, Atlanta, Georgia
Oct 2014
Research & Collaboration: What Are CF Pharmacists
Doing? ACPE-accredited continuing education presentation at the
pharmacist caregiver session at the North American Cystic Fibrosis
Conference, Atlanta, Georgia
Aug 2014
Cystic Fibrosis in Pediatrics. Seminar presentation to 3rd year
medical students at the University of Utah School of Medicine,
Salt Lake City, Utah
July 2014
Update on Pediatric Asthma. Seminar presentation to family
practice residents at University of Utah School of Medicine, Salt
Lake City, Utah.
Feb 2014
Cystic Fibrosis 101: What the Pharmacist Needs to Know. ACPEaccredited continuing education presentation webinar for
Walgreen’s and Cystic Fibrosis Services pharmacists, Deerfield,
Illinois
Oct 2013
Clinical Controversies in CF Care for Pharmacists. ACPEaccredited continuing education presentation at the pharmacist
caregiver session at the North American Cystic Fibrosis
Conference, Salt Lake City, Utah
Oct 2013
Optimization of Anti-pseudomonal and Anti-staphylococcal
Antibiotics in CF Exacerbations. Short Course session. North
American Cystic Fibrosis Conference, Salt Lake City, Utah
May 2013
Optimization of Anti-pseudomonal Antibiotics in CF Pulmonary
Exacerbations. Pulmonary and Critical Care Grand Rounds, Utah
Valley Regional Medical Center, Provo, Utah
Feb 2013
Optimization of Beta-lactam Antibiotics in Cystic Fibrosis and
Beyond: Intermittent and Extended/Continuous Infusions.
Pediatric Grand Rounds, Intermountain Primary Children’s
Medical Center, Salt Lake City, Utah
Jan 2013
Update on Pediatric Asthma. Seminar presentation to family
practice residents at University of Utah School of Medicine, Salt
Lake City, Utah.
5/8/2017
Jeffery Zobell
6
Oct 2012
Pharmacists Collaborating to Optimize Anti-staphylococcal and
Anti-pseudomonal Antibiotic Utilization in CF: Optimization of
Intermittent Anti-pseudomonal Beta-Lactams. ACPE-accredited
continuing education presentation at the pharmacist caregiver
session at the North American Cystic Fibrosis Conference,
Orlando, Florida
Oct 2012
Optimization of Intermittent Anti-pseudomonal Beta-lactams in
Acute Pulmonary Exacerbations. Short-Course session. North
American Cystic Fibrosis Conference. Orlando, Florida.
Apr 2012
Pro-Con: Continuous Infusion vs. Scheduled Antibiotics. ACPEaccredited continuing education at 2012 Pediatric Pharmacy
Advocacy Group Conference, Houston, Texas
Nov 2011
Leonard W, Zobell JT, Ensign R, Korgenski K, Chatfield BA.
Retrospective Evaluation of Appropriate Duration of Intravenous
Antibiotic Therapy for Acute CF Exacerbations. Workshop
session presentation. North American Cystic Fibrosis Conference.
Anaheim, California.
Nov 2011
Rational Approach to Treating Infection in Pulmonary
Exacerbations—Symposium Co-Chair. Symposium #10 North
American Cystic Fibrosis Conference. Anaheim, California.
Sept 2011
Basics of Pediatrics. Lecture to 3rd year pharmacy students at the
University of Arizona College of Pharmacy, Tucson, Arizona
July 2011
Update on Pediatric Asthma. Seminar presentation to family
practice residents at University of Utah School of Medicine, Salt
Lake City, Utah.
May 2011
Childhood vs. Adult Onset Asthma. 26th Annual Advances in
Respiratory Care Conference. Las Vegas, Nevada
Nov 2010
Childhood vs. Adult Onset Asthma. CME-accredited continuing
education for Utah Telehealth Series. Salt Lake City, Utah
Oct 2010
Continuous Infusion Beta-Lactam Therapy for Management of
Acute Exacerbations in Cystic Fibrosis: Lessons Learned. ACPEaccredited continuing education at 2010 Pediatric Pharmacy
Advocacy Group Conference, St. Charles, Missouri
Oct 2009
Starting From Scratch: The Process of Developing Pharmacy
Services in a Pediatric CF Center. ACPE-accredited continuing
5/8/2017
Jeffery Zobell
7
education presentation at the pharmacist caregiver session at the
North American Cystic Fibrosis Conference, Minneapolis,
Minnesota
Oct 2008
Cryptosporidium and other GI Pathogens in CF: Coming to a
POOL near you. ACPE-accredited continuing education
presentation at the pharmacist caregiver session at the North
American Cystic Fibrosis Conference, Orlando, Florida
Oct 2008
Zobell JT, Hoopes L, Hyer J, MacKay M, Koopmeiners K,
Hamilton J, Pfitzner M, Chatfield BA. Prospective evaluation of
the delivery of intravenous antibiotics during CF exacerbations.
Workshop session presentation. North American Cystic Fibrosis
Conference, Orlando, Florida
Oct 2008
Basics of Pediatrics. Lecture to 3rd year pharmacy students at the
University of Arizona College of Pharmacy, Tucson, Arizona
April 2008
Update of Pediatric Asthma. ACPE-accredited continuing
education presentation at Utah Pharmacists Association annual
meeting, St. George, Utah.
April 2007
The Ins and Outs of Cystic Fibrosis: A Pharmacy Perspective.
ACPE-accredited Continuing Education presentation at
Intermountain Primary Children’s Medical Center, Salt Lake City,
Utah.
March 2007
Update on Pediatric Asthma. Seminar presentation to family
practice residents at University of Utah School of Medicine, Salt
Lake City, Utah.
Oct 2006
LABAs: Is the Black Box Warning Warranted? Seminar
presentation to clinical pharmacy staff at Intermountain Primary
Children’s Medical Center, Salt Lake City, Utah.
Posters
Dec 2014
MacKay MW, Anderson C, Zobell J, Cash J, Boehme S.
Frequency and Severity of Parenteral Nutrition Medication Errors
at a Large Children’s Hospital after Implementation of Electronic
Ordering and Compounding. American Health-Systems Pharmacy
Midyear Meeting, Anaheim , California
Oct 2014
Holcomb KA, Young DC, Zobell JT, Bhakta Z, Marshall B,
Olivier K, Nick J, Saiman L. Survey of Antibiotic Utilization for
Treatment of Mycobacterium abscessus Infection Amongst Cystic
5/8/2017
Jeffery Zobell
8
Fibrosis Foundation (CFF)-Accredited Care Centers. North
American Cystic Fibrosis Conference, Atlanta, Georgia
Oct 2014
Louie JM, Young DC, Zobell JT, Bhakta Z, Nickman N, Stevens
V, Biltaji E, Carveth H, Liou TG. Safety of Continuous Infusion
Beta-Lactam Antibiotics in Adult Cystic Fibrosis Patients During
an Acute Pulmonary Exacerbation. North American Cystic
Fibrosis Conference, Atlanta, Georgia
Oct 2014
Zobell JT, Ferdinand C, Kemper A, Gorney N, Leonard W, Olson
J. Efficacy of High Dose vs. Standard Dose Ceftazidime in
Pediatric CF Patients. North American Cystic Fibrosis
Conference, Atlanta, Georgia
Oct 2014
Zobell JT, McDade EJ, Peters SJ, Duval MA, Epps K, Kittell F,
Sema C, Pettit RS. Antibiotic Utilization in CF Exacerbations: A
Pharmacist Approach. North American Cystic Fibrosis
Conference, Atlanta, Georgia
Oct 2013
Chatfield BA, Zobell JT, Stewart J, Hamilton J. Improved
Delivery Time from Inpatient Admission to Antibiotic
Administration for the CF Patient. North American Cystic Fibrosis
Conference, Salt Lake City, Utah
Oct 2013
Hunt T, Zobell JT, MacKay M, McDonald CM, Olson J, Dickey
M, Phillips A, Daly J, Chatfield BA. Sterility Analysis of Cystic
Fibrosis Liquid Multivitamins. North American Cystic Fibrosis
Conference, Salt Lake City, Utah
Oct 2013
Bhakta ZN, Young DC, Zobell JT, Kuhn RJ, Sabadosa K, Chin M,
Marshall BC. A Survey of the Pharmacist’s Role at US CFFAccredited Centers – A Director’s Perspective. North American
Cystic Fibrosis Conference, Salt Lake City, Utah
Oct 2013
Young DC, Zobell JT, Kuhn RJ, Chin M, Marshall B. A Survey of
Pharmacists Providing Care at US CFF-Accredited Centers. North
American Cystic Fibrosis Conference, Salt Lake City, Utah
Oct 2013
Zobell JT, Darnell L, Ferdinand C, Kemper A, Olson J, Chatfield
BA. High Dose Intermittent Ceftazidime Administration in
Pediatric Cystic Fibrosis Patients. North American Cystic Fibrosis
Conference, Salt Lake City, Utah
Oct 2013
Zobell JT, Epps K, Young DC, Hatch M, Olson J, Ampofo K, Chin
M, Marshall B, Dasenbrook EC. Utilization of Antibiotics for
Methicillin-Resistant Staphylococcus Aureus Infection in CF
5/8/2017
Jeffery Zobell
9
Patients. North American Cystic Fibrosis Conference, Salt Lake
City, Utah
May 2013
Stockmann C, Sherwin C, Zobell J, Lubsch L, Young D, Olson J,
Noyes B, Ampofo K, Spigarelli M. Population Pharmacokinetics
of Vancomycin Used in the Treatment of Pediatric Cystic Fibrosis
Pulmonary Exacerbations. American Conference on
Pharmacometrics, Fort Lauderdale, Florida
May 2013
Sherwin C, Stockmann C, Zobell J, McCrory B, Wisdom M,
Young D, Olson J, Ampofo K, Spigarelli M. A Pharmacokinetic
Evaluation of Tobramycin Administered One, Two, and Three
Times Daily to Children with Cystic Fibrosis. American
Conference on Pharmacometrics, Fort Lauderdale, Florida
Nov 2011
Zobell JT, Stockmann C, Young DC, Cash J, et al. Population
pharmacokinetic (PK) and pharmacodynamic (PD) modeling of
ticarcillin-clavulanate in pediatric CF patients. Poster presentation.
North American Cystic Fibrosis Conference, Anaheim, California
Nov 2011
Leonard W, Zobell JT, Ensign R, Korgenski K, et al.
Retrospective evaluation of appropriate duration of intravenous
antibiotic therapy for acute CF exacerbations. Poster presentation.
North American Cystic Fibrosis Conference, Anaheim, California
Dec 2010
Bennett W, Zobell J, Korgenski K, Chatfield B. Retrospective
evaluation of the appropriate duration of intravenous antibiotic
therapy for acute exacerbations of cystic fibrosis. Poster
presentation. ASHP Mid-year meeting, Anaheim, California
Dec 2010
MacKay M, Gerdy C, Keyser B, Andrews S, Zobell J.
Understanding missing doses in a pediatric hospital. Poster
presentation. ASHP Mid-year meeting, Anaheim, California.
Oct 2009
Lin E, Zobell J, MacKay M, Korgenski K, Daly J, Ensign R,
Chatfield BA. Retrospective analysis of the role of proton pump
inhibitors as a risk factor in Clostridium difficile infections in
pediatric cystic fibrosis patients. Poster presentation. North
American Cystic Fibrosis Conference, Minneapolis, Minnesota
Oct 2009
Halton K, Zobell J, MacKay M, Ensign R, Chatfield BA.
Evaluation of the effectiveness of a Staphylococcus aureus
eradication/treatment protocol in pediatric cystic fibrosis patients.
Poster presentation. North American Cystic Fibrosis Conference,
Minneapolis, Minnesota
5/8/2017
Jeffery Zobell
10
Oct 2009
Chatfield BA, Zobell J, Seidelman J, Mundorf M, Richards K.
Compliance in prescribing of CF medications of a CF specific
medication tracker. Poster presentation. North American Cystic
Fibrosis Conference. Minneapolis, Minnesota
Oct 2009
Zobell J, Olson J, Cash J, Mitchell M, et al. Evaluation of a
change in once daily tobramycin pharmacokinetic monitoring in
pediatric CF patients. Poster presentation. North American Cystic
Fibrosis Conference. Minneapolis, Minnesota
Oct 2008
Zobell JT, Hoopes L, Hyer J, MacKay M, Koopmeiners K,
Hamilton J, Pfitzner M, Chatfield BA. Prospective evaluation of
the delivery of intravenous antibiotics during CF exacerbations.
Poster presentation. North American Cystic Fibrosis Conference,
Orlando, Florida
Oct 2008
McDonald K, Zobell J, MacKay M. Vitamin D status in children
with CF. Poster presentation. North American Cystic Fibrosis
Conference, Orlando, Florida
Oct 2007
Zobell JT, Hyer J, MacKay M, Koopmeiners K, Chatfield BA.
Improving delivery of intravenous antibiotics during CF
exacerbations. Poster presentation. North American Cystic
Fibrosis Conference, Anaheim, California.
Oct 2007
Chatfield BA, Siedelman J, Hyer JS, Zobell, JT, Zakrzewski D,
Richards, K. Medtracker: Utilizing a patient medication tracking
system to improve quality of care in a pediatric cystic fibrosis
clinic. Poster presentation. North American Cystic Fibrosis
Conference, Anaheim, California.
May 2007
Zobell JT, Boehme S, MacKay M, Hight S, Hight M.
Retrospective analysis of a heparin dosing protocol at a tertiary
pediatric medical center. Poster presentation. Western States
Residency Conference, Asilomar, California.
Dec 2006
Zobell JT, Boehme S, MacKay M, Hight S, Hight M.
Retrospective analysis of a heparin dosing protocol at a tertiary
pediatric medical center. Poster presentation. ASHP Mid-year
meeting, Anaheim, California.
Electronic Databases
Lexi-Comp® Online
5/8/2017
Jeffery Zobell
11
Cystic Fibrosis dosing information for aztreonam, cefepime, ceftazidime,
colistimethate sodium, imipenem-cilastatin, meropenem, piperacillin-tazobactam, and
ticarcillin-clavulanate drug monographs
Up to Date®
Cystic Fibrosis dosing information for aztreonam, cefepime, ceftazidime,
colistimethate sodium, imipenem-cilastatin, meropenem, piperacillin-tazobactam, and
ticarcillin-clavulanate drug monographs
Research
The Impact of Individualized, Pharmacist-provided Asthma Education in an Asthma Care
Pharmacy
 Co-Principal Investigator
 Multi-centered, prospective, observational study
Intermittent Vancomycin Administration in Cystic Fibrosis Patients
 Principal Investigator
 Multi-centered, retrospective pharmacokinetic and pharmacodynamic analysis
Pharmacokinetic analysis of continuous infusion beta-lactam antibiotics (CIBL-PK) for
CF exacerbations
 Co-Investigator
 Multi-centered, retrospective pharmacokinetic and pharmacodynamic analysis
Pharmacokinetic/Pharmacodynamic (PK-PD) analysis of tobramycin cystic fibrosis
patients
 Principal Investigator
 Multi-centered, retrospective pharmacokinetic and pharmacodynamic analysis
A Survey of the Pharmacists Provided Care at U.S. CFF-accredited Centers
 Co-investigator
 Survey analysis of pharmacist care provided at CFF-accredited centers
A Survey of the Pharmacist’s Role at U.S. CFF-accredited Centers
 Co-investigator
 Survey analysis of CFF Center Directors about role of pharmacists at their centers
A Survey of the Utilization of Anti-Staphylococcal Antibiotics at U.S. CF Centers
 Principal Investigator
 Survey analysis of anti-staphylococcal utilization and dosing practices across the
U.S.
Sterility Analysis of Cystic Fibrosis Liquid Multivitamins
 Co-investigator
 Residency pilot study
Survey of tobramycin and anti-pseudomonal beta-lactam antibiotics utilization in the
treatment of pulmonary exacerbations in cystic fibrosis patients: A pharmacist approach
 Principal Investigator
 Survey analysis of tobramycin and anti-pseudomonal beta-lactam utilization and
dosing practices among dedicated CF pharmacists across the U.S.
5/8/2017
Jeffery Zobell
12
Retrospective analysis of the rate of pneumococcal polysaccharide immunization in
hospitalized pediatric asthma, cystic fibrosis, and congenital heart disease patients in
Utah
 Principal investigator
 Retrospective study of pneumococcal immunization rates in high-risk populations
Survey of utilization of anti-pseudomonal beta-lactam therapy in CF patients at U.S. CF
Centers: follow-up
 Principal Investigator
 Survey analysis of anti-pseudomonal beta-lactam utilization and dosing practices
across the U.S. as a follow-up study
Assessment of the impact of pediatric knowledge by pharmacy students via a newly
developed pediatric pharmacy curriculum
 Principal Investigator
 Questionnaire analysis of 3rd year pharmacy students at the University of Utah
College of Pharmacy on pediatric knowledge
Research Grants
Clinical Pharmacy Research Award from the Primary Children’s Foundation for Sterility
Analysis of Cystic Fibrosis Liquid Multivitamins
Marriner S. Eccles Foundation Grant for The Impact of Individualized, Pharmacistprovided Asthma Education in an Asthma Care Pharmacy
Professional Involvement
Manuscript Reviewer:
 Journal of Pediatric Pharmacology and Therapeutics
 Pediatric Pulmonology
 Clinical Therapeutics
 Annals of Pharmacotherapy
Coursemaster, PCTH 7320 Pediatric Pharmacotherapy Elective comprising of 15 lectures
for 3rd year pharmacy students, The University of Utah College of Pharmacy
 Teach 3 lectures of course
o Introduction to Course/Pediatrics 101/Age Definitions
o Pediatric Pharmacokinetics & Pharmacodynamics
o Pediatric Pulmonology: Cystic Fibrosis and Asthma
 Development of Cases and Exams
 Coordination of student shadow experience at Intermountain Primary
Children’s Hospital
 Coordination of 4 non-didactic guest speaker lectures
Pediatric Pharmacotherapy Module Leader comprising of 5 lectures in PCTH 7312 Drug
and Disease Therapy II, The University of Utah College of Pharmacy
5/8/2017
Jeffery Zobell
13

Teach 1st 2 lectures of module
o Introduction to Pediatric Pharmacy: Pediatric Age Groups, PK/PD
differences
o Pediatric Dosage Calculations, Therapeutic Drug Monitoring, and
Pediatric Dosage Forms
 Development of Cases and Exam
Instructor, PCTH 5113 Introduction to Pharmacy Practice, The University of Utah
College of Pharmacy since 2008
 Teach Basics of Pediatrics Workshop lecture
Adjunct Assistant Professor in Pharmacotherapy, The University of Utah College of
Pharmacy
Faculty Advisor, Utah Pediatric Pharmacy Group (UPeds), Pediatric Pharmacy Advocacy
Group Student Chapter at University of Utah College of Pharmacy
Seminar Mentor, 2 Pharmacy students each semester from University of Utah College of
Pharmacy
Clinical Instructor in Pharmacy Practice and Science, The University of Arizona College
of Pharmacy
Affiliate Faculty, Idaho State University College of Pharmacy
Co-coordinator, North American Cystic Fibrosis Foundation Pharmacist Mentorship
Program
Honors and Awards
2014
Leadership Excellence Awards in Pharmacy (L.E.A.P) Silver
Award Winner, Baxter Healthcare, American Health-Systems
Pharmacy Midyear Meeting, Anaheim, California
2014
Nominated for University of Utah College of Pharmacy P3
Teacher of the Year
2014
Nominated for University of Utah College of Pharmacy Preceptor
of the Year
2014
Nominated for University of Utah College of Pharmacy P4
Teacher of the Year
2013
Nominated for University of Utah College of Pharmacy P3
Teacher of the Year
5/8/2017
Jeffery Zobell
14
2013
Nominated for University of Utah College of Pharmacy Preceptor
of the Year
2012
Nominated for University of Utah College of Pharmacy Preceptor
of the Year
2012
Carol Wood Spirit Award: Appreciation for the passionate care
shown to cystic fibrosis patients and their families and for being a
significant advocate for patients with CF, Cystic Fibrosis
Foundation
2011
Intermountain Primary Children’s Medical Center PGY-1
Residency Preceptor of Year
2008
Cystic Fibrosis Foundation Quality Care Award: Recognizing
Outstanding QI Processes and Accomplishments given to the
Intermountain Cystic Fibrosis Center and the University of Utah
Health Sciences Center, North American Cystic Fibrosis
Conference, Orlando, Florida.
2006
Merck Pharmaceuticals Highest Scholastic Achievement Award,
The University of Arizona, College of Pharmacy, Tucson, Arizona
2006
Mylan Pharmaceuticals Excellence in Drug Information Award,
The University of Arizona, College of Pharmacy, Tucson, Arizona
2005
Paul A. and Helen L. Portteus Scholarship for the Most
Outstanding 4th Year College of Pharmacy student (highest
academic achievement), The University of Arizona, College of
Pharmacy, Tucson, Arizona
Professional Memberships
Rho Chi Pharmacy Honor Society, Alpha Psi Chapter
Pediatric Pharmacy Advocacy Group (PPAG)
Special Skills, Licensure, Certifications, Leadership, Volunteer, and
Experiences
Language Skills:
Fluent in conversational Portuguese
Licensure:
Arizona Pharmacy License #015484 expires 10/31/2016
Utah Pharmacy License #6193395-1701 expires 09/30/2015
Utah Pharmacy Controlled Substance License #6193395-8911 expires 09/30/2015
National Provider Identifier Number (NPI): 1801290986
5/8/2017
Jeffery Zobell
15
Certification:
Basic Life Support (BLS) expires Feb 2016
Leadership:
Lead Resident for 2006-2007 residency years, Intermountain Healthcare
Pharmacy Practice Residency program (consisting of nine residents)
Volunteer
Youth soccer coach for Kaysville Parks and Recreation
Youth baseball coach for Kaysville Parks and Recreation
Experience:
Two-year service mission for The Church of Jesus Christ of Latter-day Saints in
Ribeirao Preto, Brazil
References: Available upon request
5/8/2017